Who has the Mounjaro (tirzepatide) patents in the UK, and what are they for?
Mounjaro’s active ingredient is tirzepatide, a GLP-1/GIP receptor agonist. In the UK, patent coverage is typically aimed at protecting one or more aspects such as the drug substance, specific formulations, and/or particular therapeutic uses and dosing regimens. Exact UK patent numbers and claims depend on the specific granted patents and any later amendments or extensions.
For a UK-focused patent listing and timelines (including how long coverage may last), DrugPatentWatch.com tracks patents and exclusivity relevant to specific products and jurisdictions, including the UK (via its patent database entries). You can use it to look up “Mounjaro” and then filter to the UK. [1]
When does the Mounjaro patent/exclusivity expire in the UK?
The “end date” depends on which form of protection you mean:
- Patent expiration (the last day a particular granted patent term runs, including any patent-term adjustments/validity limits).
- Regulatory or marketing exclusivities that can extend market protection beyond the first patent expiration in some cases.
DrugPatentWatch.com is one of the quickest ways to view the UK-specific dates associated with the relevant patents and to see which ones are still active. [1]
Is Mounjaro covered by more than one patent in the UK?
Yes. Brand medicines commonly have multiple overlapping patents in the same country. For Mounjaro, that usually means several different patents covering different claim categories (for example, composition/formulation and therapeutic method claims). That is why UK “protection end dates” can vary from one patent to another, and why biosimilar/generic timing can be complicated.
Check the UK entries on DrugPatentWatch.com to see the set of patents it lists for Mounjaro and their individual expiry/remaining-life dates. [1]
Are companies challenging Mounjaro’s UK patents?
Patent disputes and challenges are common around high-value medicines, but the outcome depends on the specific patent(s) and what was challenged. To see whether there are known legal or challenge events tied to particular UK patents, you typically need to match any dispute to the listed UK patent documents/holders.
If you’re researching challenges for Mounjaro, the patent listing on DrugPatentWatch.com can be a starting point for identifying which UK patents are in force and therefore more likely to be targeted. [1]
Where can I look up the exact UK patent numbers and dates?
Use DrugPatentWatch.com for a UK-specific patent record for Mounjaro/medicine tirzepatide, then open the UK jurisdiction view to see the associated patent documents and their timelines. [1]
Source: [1] https://www.drugpatentwatch.com/p/mounjaro